| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.683 | 42.233 | 82.353 | 63.072 | 46.002 | 44.371 | 30.885 |
| Total Income - EUR | - | - | - | 3.684 | 42.233 | 82.354 | 63.082 | 46.002 | 44.372 | 32.488 |
| Total Expenses - EUR | - | - | - | 9.737 | 49.396 | 80.410 | 73.200 | 64.643 | 59.112 | 46.185 |
| Gross Profit/Loss - EUR | - | - | - | -6.053 | -7.163 | 1.944 | -10.117 | -18.641 | -14.741 | -13.697 |
| Net Profit/Loss - EUR | - | - | - | -6.090 | -7.566 | 1.444 | -10.751 | -19.088 | -15.191 | -14.022 |
| Employees | - | - | - | 0 | 2 | 2 | 2 | 3 | 2 | 1 |
Check the financial reports for the company - Farmacia Visanpharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 2.187 | 1.508 | 4.838 | 15.864 | 10.878 | 5.825 | 951 |
| Current Assets | - | - | - | 11.462 | 21.256 | 23.126 | 19.371 | 14.703 | 9.879 | 1.475 |
| Inventories | - | - | - | 10.387 | 11.400 | 10.257 | 8.239 | 4.903 | 2.767 | 0 |
| Receivables | - | - | - | 306 | 4.922 | 12.039 | 10.556 | 9.390 | 6.590 | 1.453 |
| Cash | - | - | - | 770 | 4.934 | 830 | 575 | 410 | 522 | 22 |
| Shareholders Funds | - | - | - | -6.047 | -13.495 | -11.795 | -22.266 | -41.424 | -56.489 | -70.195 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 19.696 | 36.260 | 39.759 | 57.921 | 67.362 | 72.243 | 72.722 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Visanpharm S.r.l.